Adrenocortical Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2015-04-22
Clinical Trial Update: Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma [Phase 2]
A Phase 2 clinical trial of bevacizumab for adrenocortical carcinoma has been withdrawn.